FRANKLIN RESOURCES INC - ARGENX SE ownership

ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 232 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of ARGENX SE
ValueSharesWeighting
Q3 2023$89,805,172
-6.4%
182,668
-25.8%
0.05%0.0%
Q2 2023$95,994,789
+4.4%
246,311
-0.1%
0.05%0.0%
Q1 2023$91,907,509
+14.9%
246,679
+16.9%
0.05%
+9.5%
Q4 2022$79,972,907
+7.2%
211,105
-0.1%
0.04%
+2.4%
Q3 2022$74,623,000
-21.4%
211,366
-15.7%
0.04%
-12.8%
Q2 2022$94,969,000
+19.9%
250,658
-0.2%
0.05%
+46.9%
Q1 2022$79,226,000
+67.2%
251,266
+85.7%
0.03%
+88.2%
Q4 2021$47,375,000
+15.9%
135,284
-0.0%
0.02%
+13.3%
Q3 2021$40,859,000
+0.7%
135,295
+0.4%
0.02%
-6.2%
Q2 2021$40,584,000
+19.6%
134,797
+9.4%
0.02%
+14.3%
Q1 2021$33,935,000
-44.0%
123,223
-40.2%
0.01%
-46.2%
Q4 2020$60,564,000
+3.8%
205,937
-7.4%
0.03%
-7.1%
Q3 2020$58,364,000
-59.7%
222,318
-60.2%
0.03%
-62.7%
Q2 2020$144,893,000
+91.5%
558,786
-2.7%
0.08%
+47.1%
Q1 2020$75,673,000
-24.4%
574,455
-7.9%
0.05%
-3.8%
Q4 2019$100,160,000
+69.2%
623,968
+20.1%
0.05%
+65.6%
Q3 2019$59,205,000
-19.5%
519,527
+0.0%
0.03%
-17.9%
Q2 2019$73,523,000
+20.1%
519,304
+5.9%
0.04%
+18.2%
Q1 2019$61,210,000
+20.6%
490,303
-7.2%
0.03%
+6.5%
Q4 2018$50,745,000
+11.4%
528,216
-12.1%
0.03%
+34.8%
Q3 2018$45,559,000
+11.5%
600,721
+21.9%
0.02%
+9.5%
Q2 2018$40,843,000
+12.2%
492,921
+8.9%
0.02%
+16.7%
Q1 2018$36,407,000
+26.0%
452,600
-1.1%
0.02%
+28.6%
Q4 2017$28,893,000
+267.9%
457,600
+30.7%
0.01%
+250.0%
Q3 2017$7,854,000
+5.8%
350,0000.0%0.00%0.0%
Q2 2017$7,424,000350,0000.00%
Other shareholders
ARGENX SE shareholders Q2 2022
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 273,343$106,529,96717.42%
Kynam Capital Management, LP 184,300$71,827,2399.88%
Ikarian Capital, LLC 132,100$51,483,3338.20%
Avoro Capital Advisors LLC 1,263,500$492,423,8556.68%
Artia Global Partners LP 46,438$18,098,2826.24%
DCF Advisers, LLC 25,700$10,016,0615.29%
Bellevue Group AG 923,284$359,831,4735.13%
Eagle Health Investments LP 64,400$25,098,6124.69%
Paradigm Biocapital Advisors LP 150,000$58,459,5004.52%
Paradigm Biocapital Advisors LP 142,259$55,442,6004.28%
View complete list of ARGENX SE shareholders